Tardastrex ad us.vet.
Tardastrex ad us.vet.
Not authorised
- Delmadinone acetate
Product identification
Medicine name:
Tardastrex ad us.vet.
Active substance:
- Delmadinone acetate
Target species:
-
Dog
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Delmadinone acetate10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03DX91
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Germany
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Bela-Pharm GmbH & Co. KG
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 6103384.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 2/09/2024
How useful was this page?:
